~~<i id='DE54B80F1A'><strike id='DE54B80F1A'><tt id='DE54B80F1A'><pre id='DE54B80F1A'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

hotspot

author：explore 2025-10-01 02:15:34 - browse：7

Sanofi will license a new CRISPR enzyme from the startup Scribe Therapeutics in a bid to be the first to develop a safer, simpler, and more scalable cure for sickle cell disease.

The French drugmaker will pay Scribe $40 million upfront and promise another $1.2 billion in potential milestones to license a DNA-cutting enzyme called CasX for use in a potential single-infusion treatment for the serious blood disorder — what’s known as in vivo therapy.CasX was discovered in CRISPR pioneer Jennifer Doudna’s lab, which subsequently spun out Scribe.

Scribe was planning to announce the news Tuesday, but it was published early Monday by GEN.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： Ford recalls 870K F

entertainment

knowledge

explore

focus

knowledge

leisure time

PresidentBidenspeaksintheEastRoomoftheWhiteHouseonTuesday.SusanWalsh/APWASHINGTON—PresidentBiden’sad

WSS

Judge rejects Trump's request to move Stormy Daniels hush

Ending racial health disparities hinges on penalties, political will

Stanford president's case begs question: Who takes blame?

Trump lawyers meet with special counsel in Jan. 6 case as potential indictment looms

Driven by the pandemic, applicants flood public health schools

Biden announces an advanced cancer research initiative

leisure time

hotspot

entertainment

Alkermes shareholders re

Ford recalls 870K F

Dobbs anniversary: the lost opportunity of abortion as health care

Driven by the pandemic, applicants flood public health schools

Medicare proposal to cover medical devices draws a mixed reaction

Public funding for King Charles III and royals has been recalculated due to windfarm deal profits

What does generative AI mean for health care? We asked experts

A Q&A with Gavi’s Seth Berkley on vaccines, Covid, and more

Medical records are filled with copy

A Q&A with Gavi’s Seth Berkley on vaccines, Covid, and more

knowledge

‘We were in the air.’ Mississippi family recounts surviving tornado that tore mobile home apart

'Stay indoors': Escaped wild animal on the loose in Berlin prompts urgent citywide search

Texas Department of Public Safety speaks out on migrant abuse allegations

Key lawmaker blasts Congress’ efforts on addiction: ‘Shame on us’

Trump lawyers meet with special counsel in Jan. 6 case as potential indictment looms

Stanford president faces new allegations over 1999 paper

explore

focus

knowledge

leisure time